{"id":"https://openalex.org/W2914892255","doi":"https://doi.org/10.1111/dth.12848","title":"The efficacy of omalizumab in Cutaneous Mastocytosis: A case series","display_name":"The efficacy of omalizumab in Cutaneous Mastocytosis: A case series","publication_year":2019,"publication_date":"2019-01-30","ids":{"openalex":"https://openalex.org/W2914892255","doi":"https://doi.org/10.1111/dth.12848","mag":"2914892255","pmid":"https://pubmed.ncbi.nlm.nih.gov/30697883"},"language":"en","primary_location":{"id":"doi:10.1111/dth.12848","doi":"https://doi.org/10.1111/dth.12848","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dth.12848","pdf_url":null,"source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071352580","display_name":"Tiffany Hinojosa","orcid":"https://orcid.org/0000-0001-5809-698X","observed_orcids":["https://orcid.org/0000-0001-5809-698X"]},"institutions":[{"id":"https://openalex.org/I4210098535","display_name":"Center for Clinical Studies","ror":"https://ror.org/00e8qrd29","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210098535"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tiffany Hinojosa","raw_affiliation_strings":["Dermatology Department, Center for Clinical Studies, Houston, Texas"],"raw_orcid":"https://orcid.org/0000-0001-5809-698X","affiliations":[{"raw_affiliation_string":"Dermatology Department, Center for Clinical Studies, Houston, Texas","institution_ids":["https://openalex.org/I4210098535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100675517","display_name":"Daniel J. Lewis","orcid":"https://orcid.org/0000-0002-1610-5785","observed_orcids":["https://orcid.org/0000-0002-1610-5785"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. Lewis","raw_affiliation_strings":["Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas","Department of Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001595985","display_name":"Ramya Vangipuram","orcid":"https://orcid.org/0000-0002-8052-6752","observed_orcids":["https://orcid.org/0000-0002-8052-6752"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramya Vangipuram","raw_affiliation_strings":["Department of Dermatology, University of Texas Health Science Center at Houston, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Texas Health Science Center at Houston, Houston, Texas","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081358743","display_name":"Laraib Z. Safeer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laraib Safeer","raw_affiliation_strings":["School of Medicine, Baylor College of Medicine, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, Baylor College of Medicine, Houston, Texas","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024585285","display_name":"Uyen Ngoc Mui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098535","display_name":"Center for Clinical Studies","ror":"https://ror.org/00e8qrd29","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210098535"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Uyen Ngoc Mui","raw_affiliation_strings":["Dermatology Department, Center for Clinical Studies, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department, Center for Clinical Studies, Houston, Texas","institution_ids":["https://openalex.org/I4210098535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112862912","display_name":"Christopher T. Haley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098535","display_name":"Center for Clinical Studies","ror":"https://ror.org/00e8qrd29","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210098535"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Haley","raw_affiliation_strings":["Dermatology Department, Center for Clinical Studies, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department, Center for Clinical Studies, Houston, Texas","institution_ids":["https://openalex.org/I4210098535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043947276","display_name":"Sergej Naumovich Konoplev","orcid":"https://orcid.org/0000-0002-8417-7393","observed_orcids":["https://orcid.org/0000-0002-8417-7393"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergej Konoplev","raw_affiliation_strings":["Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000478173","display_name":"Stephen Keith Tyring","orcid":"https://orcid.org/0000-0002-3337-0580","observed_orcids":["https://orcid.org/0000-0002-3337-0580"]},"institutions":[{"id":"https://openalex.org/I4210098535","display_name":"Center for Clinical Studies","ror":"https://ror.org/00e8qrd29","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210098535"]},{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen K. Tyring","raw_affiliation_strings":["Department of Dermatology, University of Texas Health Science Center at Houston, Houston, Texas","Dermatology Department, Center for Clinical Studies, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Texas Health Science Center at Houston, Houston, Texas","institution_ids":["https://openalex.org/I919571938"]},{"raw_affiliation_string":"Dermatology Department, Center for Clinical Studies, Houston, Texas","institution_ids":["https://openalex.org/I4210098535"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5071352580"],"corresponding_institution_ids":["https://openalex.org/I4210098535"],"apc_list":{"value":3100,"currency":"USD","value_usd":3100},"apc_paid":null,"fwci":0.6785,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.62442992,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"32","issue":"3","first_page":"e12848","last_page":"e12848"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12600","display_name":"Eosinophilic Disorders and Syndromes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cutaneous-mastocytosis","display_name":"cutaneous mastocytosis","score":1.0},{"id":"https://openalex.org/keywords/immunoglobulin-e","display_name":"immunoglobulin E","score":0.8109999895095825},{"id":"https://openalex.org/keywords/anti-ige-therapy","display_name":"anti-IgE therapy","score":0.765999972820282},{"id":"https://openalex.org/keywords/mast-cell-proliferation","display_name":"mast cell proliferation","score":0.5690000057220459},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.9649999737739563},{"id":"https://openalex.org/keywords/subcutaneous-injection","display_name":"subcutaneous injection","score":0.6520000100135803},{"id":"https://openalex.org/keywords/tryptase","display_name":"tryptase","score":0.8029999732971191},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5910000205039978},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.9551222324371338},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.943810224533081},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7289878129959106},{"id":"https://openalex.org/C2909606595","wikidata":"https://www.wikidata.org/wiki/Q112670","display_name":"Cutaneous Mastocytosis","level":4,"score":0.7060208320617676},{"id":"https://openalex.org/C2780581156","wikidata":"https://www.wikidata.org/wiki/Q112670","display_name":"Systemic mastocytosis","level":3,"score":0.2966461181640625},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.20506122708320618},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1771794855594635},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.08534196019172668},{"id":"https://openalex.org/C2779726688","wikidata":"https://www.wikidata.org/wiki/Q191989","display_name":"Mast cell","level":2,"score":0.08296102285385132}],"mesh":[{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007073","descriptor_name":"Immunoglobulin E","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D034701","descriptor_name":"Mastocytosis, Cutaneous","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D034701","descriptor_name":"Mastocytosis, Cutaneous","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/dth.12848","doi":"https://doi.org/10.1111/dth.12848","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dth.12848","pdf_url":null,"source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},{"id":"pmid:30697883","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30697883","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic therapy","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1656622090","https://openalex.org/W2013855051","https://openalex.org/W2064547094","https://openalex.org/W2119346099","https://openalex.org/W2125206676","https://openalex.org/W2140909066","https://openalex.org/W2473728299","https://openalex.org/W2565342730","https://openalex.org/W2737266865"],"related_works":["https://openalex.org/W4402104236","https://openalex.org/W3008626066","https://openalex.org/W2140909066","https://openalex.org/W2010921759","https://openalex.org/W7098256798","https://openalex.org/W2794416473","https://openalex.org/W4415076281","https://openalex.org/W2315450193","https://openalex.org/W2155559879","https://openalex.org/W4414951951"],"abstract_inverted_index":{"BACKGROUND:":[0],"Mastocytosis":[1],"describes":[2],"a":[3,10,28,36,53,160,185],"heterogeneous":[4],"group":[5],"of":[6,13,19,59,101,108,113,149,155,177],"disorders":[7],"arising":[8],"from":[9,143],"clonal":[11],"proliferation":[12],"mast":[14],"cells.":[15],"Given":[16],"the":[17,23,57,147,153,168,175],"lack":[18],"curative":[20],"treatments":[21],"for":[22,31,56],"cutaneous":[24,60,88,102,156,192],"form,":[25],"there":[26],"is":[27,35],"significant":[29,126],"need":[30],"superior":[32],"therapies.":[33,197],"Omalizumab":[34],"recombinant":[37],"DNA-derived":[38],"humanized":[39],"IgG":[40],"monoclonal":[41],"antibody":[42],"that":[43],"selectively":[44],"binds":[45],"to":[46,120,183,195],"human":[47],"immunoglobulin":[48],"E":[49],"(IgE).":[50],"It":[51],"represents":[52],"potential":[54],"treatment":[55,114,154,187],"management":[58],"mastocytosis,":[61],"which":[62],"currently":[63],"has":[64],"no":[65],"standard":[66],"treatment.":[67],"METHODS:":[68],"Two":[69],"patients":[70,134,190],"were":[71,131],"treated":[72],"with":[73,191],"subcutaneous":[74],"omalizumab":[75,181],"300":[76],"mg":[77,164],"every":[78],"4":[79],"weeks.":[80,124],"DISCUSSION:":[81],"Patient":[82,95],"1":[83],"experienced":[84,135],"50%":[85],"reduction":[86],"in":[87,93,128,152,189],"infiltration":[89],"and":[90,104,118],"moderate":[91],"improvement":[92],"pruritus.":[94,109],"2":[96],"underwent":[97],"90%":[98],"complete":[99],"clearance":[100],"lesions":[103],"reported":[105],"full":[106],"resolution":[107],"The":[110],"median":[111],"duration":[112],"was":[115,122,170],"24":[116],"weeks":[117],"time":[119],"response":[121],"8":[123],"No":[125],"changes":[127],"tryptase":[129],"levels":[130],"observed.":[132],"Both":[133],"injection":[136],"site":[137],"reactions.":[138],"CONCLUSION:":[139],"We":[140],"provide":[141],"evidence":[142],"two":[144],"cases":[145],"supporting":[146],"efficacy":[148],"IgE-mediated":[150],"therapy":[151],"mastocytosis.":[157],"Even":[158],"at":[159],"higher-than-standard":[161],"dose":[162],"(300":[163],"vs.":[165],"150":[166],"mg),":[167],"drug":[169],"well-tolerated.":[171],"As":[172],"we":[173],"await":[174],"results":[176],"pivotal":[178],"clinical":[179],"trials,":[180],"appears":[182],"be":[184],"promising":[186],"option":[188],"mastocytosis":[193],"unresponsive":[194],"traditional":[196]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-02-21T00:00:00"}